Figure 1.
Predicted net fluid loss at 72 hours, based on a multivariate model containing qualifying furosemide dose, mode of administration (bolus or continuous infusion), and an interaction term. Similar results (e.g., greater net fluid loss at lower qualifying doses with a bolus strategy) were obtained when stratified by intravenous dose intensity (data not shown).